Percutaneous radiofrequency ablation for stage B1 of modified Bolondi’s subclassification for intermediate-stage hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma is considered the most common cause of hepatic focal lesions in Egypt. TACE is still the recommended treatment approach for patients in the intermediate stage. In the current research, we evaluated the safety and efficacy of percutaneous radiofrequency a...
Saved in:
| Main Authors: | Ragaey Ahmad Eid, Ali M. Abdel Fattah, Alaa Farouk Haseeb, Ahmed Moheyeldien Hamed, Marwa Abdallah Shaker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2024-11-01
|
| Series: | Egyptian Liver Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43066-024-00388-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL CASE OF BCLC STAGE B HEPATOCELLULAR CARCINOMA WITH A COMBINED TREATMENT
by: Zagorulko Aleksey Ivanovich, et al.
Published: (2024-12-01) -
Efficacy of therapies for intermediate-stage hepatocellular carcinoma: systematic review and network meta-analysis
by: Shaoqi Zong, et al.
Published: (2025-07-01) -
Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
by: Reham Ashour, et al.
Published: (2024-11-01) -
Development of an Ultra-high-efficient Two-stage Compression Water-cooled Screw Chiller
by: Zhang Zhiping, et al.
Published: (2023-01-01) -
IMPACT OF VARIOUS TREATMENT STRATEGIES ON LONG-TERM TREATMENT OUTCOMES IN PATIENTS WITH STAGE IAG3 ENDOMETRIAL CANCER
by: S. A. Mavrichev
Published: (2018-04-01)